Patsnap stands at the forefront of innovation intelligence, leveraging advanced AI to transform the landscape of intellectual property (IP) and research & development (R&D). With its domain-specific Large Language Model, PatsnapGPT, the platform offers unparalleled insights and efficiency, enabling users to automate and augment their workflows like never before.
At the heart of Patsnap's offering is its ability to increase productivity for IP tasks by an impressive 75%, while simultaneously reducing overall R&D costs by 25%. This is achieved through the automation of time-consuming tasks, allowing teams to dedicate more time to deep work and strategic initiatives. PatsnapGPT, trained on over 3.5 billion data points and enriched with domain expertise from humans in the loop, consistently outperforms general-purpose LLMs across IP-oriented benchmarks and official Pharmaceutical exams.
Patsnap's comprehensive innovation database, fit for enterprises, provides instant access to tech insights from billions of data points, with answers directly linked to sources across patents and non-patent literature. This capability empowers users to make faster, more informed decisions, from checking novelty to protecting innovation with workflows designed for both IP and R&D teams.
Trusted by 15,000 innovators worldwide, Patsnap has proven its value across various industries. Customer stories highlight the platform's impact, from integrating sequence searching with patent analysis to significantly accelerating idea generation with AI and TRIZ-based innovation approaches.
Patsnap's solutions extend beyond IP to R&D, offering tools to accelerate research and development of new breakthroughs, reduce R&D costs, and empower the entire R&D team with access to market-leading, global data. The platform's AI tools, built on TRIZ and FMEA, enable rapid scoping of technical solutions and risk assessment with references linked from patents and non-patent literature.
In the realm of IP, Patsnap turns weeks of Freedom to Operate (FTO) and prior art search into minutes, with AI tools, collaboration, and global data. The platform's ability to analyze hundreds of bio sequences and chemical structures in a few clicks exemplifies its efficiency and depth of analysis.
Patsnap's influence and success are further evidenced by its recognition in the media and its achievement of surpassing US$100 million in annual recurring revenue, reinforcing its position as a global leader in IP and R&D intelligence. With Patsnap, the future of innovation intelligence is here, offering more impact with less waste and transforming how IP and R&D innovate with AI.
